Elena Goicoechea de Jorge
Overview
Explore the profile of Elena Goicoechea de Jorge including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
2006
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Martin-Ambrosio Domenech A, Gonzalez Sanz S, Marquez Tirado B, Juana-Lopez L, Goicoechea de Jorge E, Rodriguez de Cordoba S, et al.
Front Immunol
. 2025 Feb;
16:1522651.
PMID: 39944688
Factor H-related proteins (FHRs) are found in mice, but their equivalence to human FHRs remains uncertain. This study identifies three FHRs in mouse plasma (FHR-B, FHR-C, and FHR-E) and focuses...
2.
Vivarelli M, Barratt J, Beck Jr L, Fakhouri F, Gale D, Goicoechea de Jorge E, et al.
Kidney Int
. 2024 Jun;
106(3):369-391.
PMID: 38844295
Uncontrolled complement activation can cause or contribute to glomerular injury in multiple kidney diseases. Although complement activation plays a causal role in atypical hemolytic uremic syndrome and C3 glomerulopathy, over...
3.
Lucientes-Continente L, Fernandez-Juarez G, Marquez-Tirado B, Jimenez-Villegas L, Acevedo M, Cavero T, et al.
Kidney Int
. 2023 Nov;
105(1):177-188.
PMID: 37923132
Activation of the alternative pathway (AP) of complement is involved in the pathogenesis of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV), although the underlying molecular mechanisms are unclear. To gain insight...
4.
Caravaca-Fontan F, Cavero T, Diaz-Encarnacion M, Cabello V, Ariceta G, Quintana L, et al.
Kidney360
. 2023 Mar;
4(5):659-672.
PMID: 36996481
No abstract available.
5.
Lucientes-Continente L, Marquez-Tirado B, Goicoechea de Jorge E
Immunol Rev
. 2022 Nov;
313(1):25-45.
PMID: 36382387
The factor H (FH) protein family is emerging as a complex network of proteins controlling the fate of the complement alternative pathway (AP) and dictating susceptibility to a wide range...
6.
Banerjee P, Veuskens B, Goicoechea de Jorge E, Jozsi M, Baeumner A, Steiner M, et al.
Mol Immunol
. 2022 Sep;
151:166-182.
PMID: 36162225
After years of disappointing clinical results, the tide has finally changed and complement targeted-therapies have become a validated and accepted treatment option for several diseases. These accomplishments have revitalized the...
7.
Caravaca-Fontan F, Rivero M, Cavero T, Diaz-Encarnacion M, Cabello V, Ariceta G, et al.
Clin Kidney J
. 2022 Aug;
15(9):1737-1746.
PMID: 36003665
Background: C3 glomerulopathy is a rare and heterogeneous complement-driven disease. It is often challenging to accurately predict in clinical practice the individual kidney prognosis at baseline. We herein sought to...
8.
Cavero T, Aunon P, Caravaca-Fontan F, Trujillo H, Arjona E, Morales E, et al.
Nephrol Dial Transplant
. 2022 Aug;
38(5):1217-1226.
PMID: 36002030
Background: Thrombotic microangiopathy (TMA) is a complication of malignant hypertension (mHTN) attributed to high blood pressure (BP). However, no studies have investigated in patients with mHTN of different aetiologies whether...
9.
Poppelaars F, Goicoechea de Jorge E, Jongerius I, Baeumner A, Steiner M, Jozsi M, et al.
Front Immunol
. 2022 Jun;
13:937609.
PMID: 35707529
[This corrects the article DOI: 10.3389/fimmu.2021.660194.].
10.
Marquez-Tirado B, Gutierrez-Tenorio J, Tortajada A, Lucientes Continente L, Caravaca-Fontan F, Malik T, et al.
J Am Soc Nephrol
. 2022 May;
33(6):1137-1153.
PMID: 35545301
Background: C3 glomerulopathy (C3G) is a heterogeneous group of chronic renal diseases characterized predominantly by glomerular C3 deposition and complement dysregulation. Mutations in factor H-related (FHR) proteins resulting in duplicated...